Ilyang Pharmaceutical Co Ltd (007575) - Total Liabilities

Latest as of June 2025: ₩205.41 Billion KRW ≈ $139.20 Million USD

Based on the latest financial reports, Ilyang Pharmaceutical Co Ltd (007575) has total liabilities worth ₩205.41 Billion KRW (≈ $139.20 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Ilyang Pharmaceutical Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.

Ilyang Pharmaceutical Co Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how Ilyang Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Ilyang Pharmaceutical Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Ilyang Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Ilyang Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Q32 Bio Inc NASDAQ:QTTB	USA	$17.36 Million
GnBS Engineering Co. Ltd. KQ:382800	Korea	₩30.41 Billion
KHD Humboldt Wedag International AG XETRA:KWG	Germany	€137.23 Million
Arla Plast AB ST:ARPL	Sweden	Skr310.20 Million
DMS Propertindo Tbk PT JK:KOTA	Indonesia	Rp471.84 Billion
TDM Berhad KLSE:2054	Malaysia	RM1.07 Billion
Highlight Event Entertainment SW:HLEE	Switzerland	CHF609.16 Million
Sona Topas Tourism Industry JK:SONA	Indonesia	Rp280.21 Billion

Liability Composition Analysis (2014–2024)

This chart breaks down Ilyang Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Ilyang Pharmaceutical Co Ltd worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.87	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.87	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.46	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ilyang Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ilyang Pharmaceutical Co Ltd (2014–2024)

The table below shows the annual total liabilities of Ilyang Pharmaceutical Co Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩189.63 Billion ≈ $128.51 Million	+18.33%
2023-12-31	₩160.25 Billion ≈ $108.60 Million	-22.33%
2022-12-31	₩206.33 Billion ≈ $139.83 Million	-7.27%
2021-12-31	₩222.51 Billion ≈ $150.79 Million	+14.58%
2020-12-31	₩194.19 Billion ≈ $131.60 Million	-9.56%
2019-12-31	₩214.72 Billion ≈ $145.51 Million	-3.44%
2018-12-31	₩222.37 Billion ≈ $150.70 Million	-1.34%
2017-12-31	₩225.39 Billion ≈ $152.74 Million	+5.37%
2016-12-31	₩213.91 Billion ≈ $144.96 Million	-3.04%
2015-12-31	₩220.62 Billion ≈ $149.51 Million	-10.81%
2014-12-31	₩247.37 Billion ≈ $167.64 Million	--

About Ilyang Pharmaceutical Co Ltd

KO:007575 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$90.85 Million

₩134.06 Billion KRW

Market Cap Rank

#19470 Global

#941 in Korea

Share Price

₩7380.00

Change (1 day)

+1.79%

52-Week Range

₩7000.00 - ₩13640.00

All Time High

₩141909.13